期刊文献+

蛇毒诱导凝固抑制试验判断肝硬化凝血状态 被引量:1

下载PDF
导出
摘要 目的研究常规凝血指标在肝硬化患者的变化,探讨蛇毒诱导凝固抑制试验(PICI%)在判断肝硬化凝血状态的临床价值。方法收集肝硬化患者236例,正常对照组90例。均进行凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、PICI%的检测。结果 (1)肝硬化患者的PT明显高于对照组(P<0.01),随病情加重逐渐延长,而PICI%明显低于对照组(P<0.01),随肝功能分级变差逐渐降低,且两指标在对照组、Child-Pugh A、B、C间两两比较差异均有统计学意义(P<0.01)。(2)PICI%与PT呈负相关,且相关关系密切(相关系数r=0.649,P<0.01)。结论 PICI%能够有效反映肝硬化患者的高凝状态,可作为临床准确判断肝硬化出血或血栓的指标。PT、PICI%均可作为临床评估肝硬化患者病情进展及预后的指标。
出处 《广东医学》 CAS 北大核心 2016年第10期1540-1542,共3页 Guangdong Medical Journal
基金 广东省广州市胃肠病医学研究与转化中心资助项目(编号:201508020001)
  • 相关文献

参考文献12

  • 1李姣龙,孙飞,陈峻,徐升强,胡先泳.肝硬化患者凝血功能的检测分析[J].血栓与止血学,2015,21(2):111-112. 被引量:10
  • 2Vieira Da Rocha EC, D'Amico EA, Caldwell SH, et al. A pro- spective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation [ J ]. Clin Gastroenterol Hepatol, 2009, 7 (9) : 988 - 993.
  • 3Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro - vs anti - coagulation factors in plasma from patients with cirrhosis [ J ]. Gastroenterology, 2009, 137 (6) : 2105 - 2111.
  • 4Tripodi A, Primignani M, Lemma L, et al. Detection of the imbal- ance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method [J]. Hepatology, 2010, 52 ( 1 ) : 249 - 255.
  • 5Youngwon N, Kim J, Lira HS, et al. Coagulation Proteins Influen- cing Global Coagulation Assays in Cirrhosis: Hypereoagulability in Cirrhosis Assessed by Thrombomodulin - Induced Thrombin Gener- ation AssayIJ]. Biomed Res Int, 2013, 13: 856754.
  • 6E1 Bokl MA, Shawky A, Riad GS, et al. Procoagulant versus anti- coagulant factors in cirrhotic patients [ J ]. Arab J Gastroenterol, 2014, 15(3/4): 123-129.
  • 7中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14013
  • 8Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 9Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein throm- bosis in candidates for liver transplantation: usefulness of screening and anticoagulation [ J ]. Gut, 2005, 54 ( 5 ) : 691 - 697.
  • 10Tripodi A. Tests of Coagulation in Liver Disease [ J ]. Clin Liver Dis, 2009, 13(1) : 55 -61.

二级参考文献21

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 3Sanyal AJ.American Gastroenterological Association technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
  • 4Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.
  • 5Ataseven H,Yildrim MH,Yalniz M,et al.Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis.J Hepatol,2003,38(Suppl 2):A4177.
  • 6Farrell GC,George J,Pauline de la M.Hall,et al,eds.Fatty liver diseas:NASH and related disorders.Oxford:Blackwell Publishing,2005.159-207.
  • 7McCullough AJ,O'Connor JF.Alcoholic liver disease:proposed recommendations for the American College of Gastroenterology.Am J Gastroenterol,1998,93:2022-2036.
  • 8Stickel F,Hoehn B,Schuppan D,et al.Review article:Nutritional therapy in alcoholic liver disease.Aliment Pharmacol Ther,2003,18:357-373.
  • 9Mathurin P,Mendenhall CL,Carithers RLJr,et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH):individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.J Hepatol,2002,36:480-487.
  • 10Imperiale TF,O'Connor JB,McCullough AJ.Corticosteroids are effective in patients with severe alcoholic hepatitis.Am J Gastroenterol,1999,94:3066-3068.

共引文献14261

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部